Published on in Vol 11, No 2 (2022): February
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/33726, first published
.
Journals
- Ratzki‐Leewing A, Black J, Ryan B, Harris S. Real‐world risk factors of confirmed or probable COVID‐19 in Americans with diabetes: A prospective, community‐based study (iNPHORM). Endocrinology, Diabetes & Metabolism 2022;5(4) View
- Black J, Harris S, Ryan B, Zou G, Ratzki-Leewing A. Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US). Diabetes Therapy 2023;14(8):1299 View
- Ratzki‐Leewing A, Black J, Ryan B, Zou G, Klar N, Webster‐Bogaert S, Timcevska K, Harris S. Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States). Diabetes, Obesity and Metabolism 2023;25(10):2910 View
- Dhiman P, Ma J, Kirtley S, Mouka E, Waldron C, Whittle R, Collins G. Prediction model protocols indicate better adherence to recommended guidelines for study conduct and reporting. Journal of Clinical Epidemiology 2024;169:111287 View